| 000 | 00990 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512194935.0 | ||
| 264 | 0 | _c19800627 | |
| 008 | 198006s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(80)91134-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPearson, K | |
| 245 | 0 | 0 |
_aDanazol and liver damage. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMar 1980 |
||
| 300 |
_a645-6 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCholestasis, Intrahepatic _xchemically induced |
| 650 | 0 | 4 |
_aDanazol _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPregnadienes _xadverse effects |
| 700 | 1 | _aZimmerman, H J | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8169 _gp. 645-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(80)91134-4 _zAvailable from publisher's website |
| 999 |
_c6102733 _d6102733 |
||